Fed. Circ. Nixes Apotex Appeal In Taxotere IP Fight
The Federal Circuit on Thursday struck down an Apotex Corp. protective cross-appeal in Sanofi-Aventis SA's challenge of a lower court finding that two patents for its flagship cancer treatment Taxotere are...To view the full article, register now.
Already a subscriber? Click here to view full article